United Kingdom· GB-APID-22224011000001105
Egaten 250mg tablets
A triclabendazole product containing triclabendazole, registered in United Kingdom by Imported (Switzerland). The same ATC class is registered in 4 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Triclabendazole is registered in 4 of 19 countries.
Countries holding a registration under ATC P02BX04 (triclabendazole), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 3 of them publish a price we can compare per daily dose
Triclabendazole · ATC P02BX04
4 / 19 countries
- Franceprice
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Triclabendazole
- Manufacturer
- Imported (Switzerland)
- Country
- United Kingdom (GB)
- ATC code
- P02BX04
- ATC class
- Triclabendazole
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
278 interactions on record for triclabendazole.
Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Triclabendazole · interactions on record
278 records
- 71 severe
- 204 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Triclabendazole in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesEGATENNovartis Pharmaceuticals Corporation
- FranceEGATEN 250 mg, comprimé sécableNOVARTIS PHARMA
- NorwayEgatenNovartis
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- France · Egaten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6186439a-e46d-48a9-8fa8-3b7affed1cb9 GET /v1/drugs/6186439a-e46d-48a9-8fa8-3b7affed1cb9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "22224011000001105",
"desc": "Egaten 250mg tablets (Imported (Switzerland))",
"form": "Oral tablet",
"vpid": "22223811000001102",
"source": "dmd",
"vtm_id": "777840007",
"strength": "250 mg",
"substance": "Triclabendazole",
"ingredient": "Triclabendazole",
"supplier_code": "11821311000001101"
}See everything about triclabendazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.